Literature DB >> 7354012

Possible lack of anticholinergic effects with mianserin: a pilot study.

W H Wilson, W M Petrie, T A Ban.   

Abstract

Anticholinergic effects of mianserin, a new tetracyclic antidepressant, were studied in 5 depressed patients. Prior to and after 1 and 2 hours of the administration of 30 mg of mianserin salivary flow, pupilary response to light and palpebral fissure were measured. Analysis of data revealed a statistically significant increase in salivary flow and a statistically significant decrease in pupil diameter. There was no change in palpebral fissure size. Possible clinical implications of these findings will be discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7354012

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

1.  A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers.

Authors:  W H Wilson; H Higano; Y Papadatos; S Kelwala; T A Ban
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

Review 2.  Efficacy and side effects of mianserin, a tetracyclic antidepressant.

Authors:  A Wakeling
Journal:  Postgrad Med J       Date:  1983-04       Impact factor: 2.401

3.  Assessment of the anticholinergic effects of antidepressants in a single-dose cross-over study of salivation and plasma levels.

Authors:  L Clemmesen; P L Mikkelsen; H Lund; T G Bolwig; O J Rafaelsen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 4.  Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs.

Authors:  M V Rudorfer; W Z Potter
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

5.  Distribution of Pupil Size and Associated Factors: Results from the Population-Based Gutenberg Health Study.

Authors:  Marian Kiel; Stephanie D Grabitz; Susanne Hopf; Thomas Koeck; Philipp S Wild; Irene Schmidtmann; Karl J Lackner; Thomas Münzel; Manfred E Beutel; Norbert Pfeiffer; Alexander K Schuster
Journal:  J Ophthalmol       Date:  2022-09-09       Impact factor: 1.974

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.